Yuval Shaked

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

Oncogene

Journal for immunotherapy of cancer

Cancer discovery

Nature reviews. Cancer

Technion Israel Institute of Technology Ruth and Bruce Rappaport Faculty of Medicine

Hebrew University Hadassah Medical School (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Technion Israel Institute of Technology Ruth and Bruce Rappaport Faculty of Medicine Jul 01 2018

Israel

Professor :: Cell Biology and Cancer Science

Technion Israel Institute of Technology Ruth and Bruce Rappaport Faculty of Medicine Oct 01 2013 - Jun 30 2018

Israel

Associate Professor :: Cell Biology and Cancer Science

Technion Israel Institute of Technology Ruth and Bruce Rappaport Faculty of Medicine Aug 01 2008 - Sep 30 2013

Israel

Assistant Professor :: Cell Biology and Cancer Science

Sunnybrook Health Sciences Centre Oct 01 2002 - Jul 31 2008

Canada

Post doctoral fellow :: Medical Biophysics

Education History

Hebrew University Hadassah Medical School Oct 01 1997 - Sep 22 2002

Israel

PHD :: Neurology

Publications

Jai Prakash, Yuval Shaked
The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics. Cancer discovery 14 (8) (2024)
Jai Prakash, Yuval Shaked
The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics. Cancer discovery 14 (8) (2024)
Avital Vorontsova, Tim J Cooper, Jozafina Haj-Shomaly, Madeleine Benguigui, Sapir Levin, Bar Manobla, Rotem Menachem, Michael Timaner, Ziv Raviv, Yuval Shaked
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors. Oncogene 42 (10) (2023)
Avital Vorontsova, Tim J Cooper, Jozafina Haj-Shomaly, Madeleine Benguigui, Sapir Levin, Bar Manobla, Rotem Menachem, Michael Timaner, Ziv Raviv, Yuval Shaked
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors. Oncogene 42 (10) (2023)
Avital Vorontsova, Tim J Cooper, Jozafina Haj-Shomaly, Madeleine Benguigui, Sapir Levin, Bar Manobla, Rotem Menachem, Michael Timaner, Ziv Raviv, Yuval Shaked
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors. Oncogene (2023)
Avital Vorontsova, Tim J Cooper, Jozafina Haj-Shomaly, Madeleine Benguigui, Sapir Levin, Bar Manobla, Rotem Menachem, Michael Timaner, Ziv Raviv, Yuval Shaked
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors. Oncogene 42 (10) (2023)
Kelvin K Tsai, Byoung-Il Bae, Chung-Chi Hsu, Li-Hsin Cheng, Yuval Shaked
Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers. Cancer research (2023)
Avital Vorontsova, Tim J Cooper, Jozafina Haj-Shomaly, Madeleine Benguigui, Sapir Levin, Bar Manobla, Rotem Menachem, Michael Timaner, Ziv Raviv, Yuval Shaked
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors. Oncogene (2023)
Avital Vorontsova, Tim J Cooper, Jozafina Haj-Shomaly, Madeleine Benguigui, Sapir Levin, Bar Manobla, Rotem Menachem, Michael Timaner, Ziv Raviv, Yuval Shaked
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors. Oncogene 42 (10) (2023)
Ksenia Magidey-Klein, Tim J Cooper, Ksenya Kveler, Rachelly Normand, Tongwu Zhang, Michael Timaner, Ziv Raviv, Brian P James, Roi Gazit, Ze'ev A Ronai, Shai Shen-Orr, Yuval Shaked
IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells. Journal for immunotherapy of cancer 9 (6) (2022)
Michal Harel, Coren Lahav, Eyal Jacob, Nili Dahan, Itamar Sela, Yehonatan Elon, Shani Raveh Shoval, Galit Yahalom, Iris Kamer, Alona Zer, Ofer Sharon, David P Carbone, Adam P Dicker, Jair Bar, Yuval Shaked
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade. Journal for immunotherapy of cancer 10 (6) (2022)
Tal Kan, Erik Feldman, Michael Timaner, Ziv Raviv, Shai Shen-Orr, Ami Aronheim, Yuval Shaked
IL-31 induces antitumor immunity in breast carcinoma. Journal for immunotherapy of cancer 8 (2) (2021)
Irina Khononov, Eyal Jacob, Ella Fremder, Nili Dahan, Michal Harel, Ziv Raviv, Boris Krastev, Yuval Shaked
Host response to immune checkpoint inhibitors contributes to tumor aggressiveness. Journal for immunotherapy of cancer 9 (3) (2021)
Maryna Bondarenko, Marion Le Grand, Yuval Shaked, Ziv Raviv, Guillemette Chapuisat, Cécile Carrère, Marie-Pierre Montero, Mailys Rossi, Eddy Pasquier, Manon Carré, Anne Isabelle Bertozzi
Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer. Cancers 13 (9) (2021)
Avital Vorontsova, Tal Kan, Ziv Raviv, Yuval Shaked
The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor Microenvironment. Journal of clinical medicine 9 (12) (2020)
Tamar Barenholz-Cohen, Yulia Merkher, Jozafina Haj, Dvir Shechter, Daniela Kirchmeier, Yuval Shaked, Daphne Weihs
Lung mechanics modifications facilitating metastasis are mediated in part by breast cancer-derived extracellular vesicles. International journal of cancer 147 (10) (2020)
Yuval Shaked
The pro-tumorigenic host response to cancer therapies. Nature reviews. Cancer 19 (12) (2019)
Michael Timaner, Yuval Shaked
Elucidating the roles of ASPM isoforms reveals a novel prognostic marker for pancreatic cancer. The Journal of pathology 250 (2) (2019)

Yuval Shaked.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yuval Shaked